Cited by 16Retinal Imaging and AnalysisRetinal Diseases and TreatmentsArtificial Intelligence in Healthcare

Predicting 1, 2 and 3 year emergent referable diabetic retinopathy and maculopathy using deep learning

Open access
Nderitu, Paul, Nunez do Rio, Joan M., Webster, Laura, Mann, Samantha, Cardoso, M. Jorge, Modat, Marc, Hopkins, David, Bergeles, Christos +1 more·2024·Communications Medicine

Abstract

BACKGROUND: Predicting diabetic retinopathy (DR) progression could enable individualised screening with prompt referral for high-risk individuals for sight-saving treatment, whilst reducing screening burden for low-risk individuals. We developed and validated deep learning systems (DLS) that predict 1, 2 and 3 year emergent referable DR and maculopathy using risk factor characteristics (tabular DLS), colour fundal photographs (image DLS) or both (multimodal DLS). METHODS: From 162,339 development-set eyes from south-east London (UK) diabetic eye screening programme (DESP), 110,837 had eligible longitudinal data, with the remaining 51,502 used for pretraining. Internal and external (Birmingham DESP, UK) test datasets included 27,996, and 6928 eyes respectively. RESULTS: Internal multimodal DLS emergent referable DR, maculopathy or either area-under-the receiver operating characteristic (AUROC) were 0.95 (95% CI: 0.92-0.98), 0.84 (0.82-0.86), 0.85 (0.83-0.87) for 1 year, 0.92 (0.87-0.96), 0.84 (0.82-0.87), 0.85 (0.82-0.87) for 2 years, and 0.85 (0.80-0.90), 0.79 (0.76-0.82), 0.79 (0.76-0.82) for 3 years. External multimodal DLS emergent referable DR, maculopathy or either AUROC were 0.93 (0.88-0.97), 0.85 (0.80-0.89), 0.85 (0.76-0.85) for 1 year, 0.93 (0.89-0.97), 0.79 (0.74-0.84), 0.80 (0.76-0.85) for 2 years, and 0.91 (0.84-0.98), 0.79 (0.74-0.83), 0.79 (0.74-0.84) for 3 years. CONCLUSIONS: Multimodal and image DLS performance is significantly better than tabular DLS at all intervals. DLS accurately predict 1, 2 and 3 year emergent referable DR and referable maculopathy using colour fundal photographs, with additional risk factor characteristics conferring improvements in prognostic performance. Proposed DLS are a step towards individualised risk-based screening, whereby AI-assistance allows high-risk individuals to be closely monitored while reducing screening burden for low-risk individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43856-024-00590-z

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [29]Arik, S. O. & Pfister, T. TabNet: attentive interpretable tabular learning. arXiv:1908.07442. https://ui.adsabs.harvard.edu/abs/2019arXiv190807442A (2019). · arXiv
  2. [37]Nderitu, P. Github Code Respository: Automated Image Curation in Diabetic Retinopathy Screening using Deep Learning, https://github.com/pnderitu/DUK_Automated_Curation (2022). PMC9249740 35778615

Cited by

Sorted by citations

Authors
Nderitu, P., Nunez do Rio, J. M., Webster, L., Mann, S., Cardoso, M. J., Modat, M., Hopkins, D., Bergeles, C., & Jackson, T. L.
Affiliations
  • King's College London (GB)
  • St Thomas' Hospital (GB)
  • Kings Health Partners (GB)
Corresponding author
Nderitu, Paul
Venue
Communications Medicine
Published
2024-08-21
Volume
4
Issue
1
Pages
167-167
ISSN
2730-664X (ISSN-L)
OpenAlex
W4401793494
Cited by
16
References
34
Citations by year
2026: 10 · 2025: 6
FWCI
4.06
Type
journal article
Language
en
Open access
Locations
  • Communications Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
Funders
  • Wellcome Trust
  • Diabetes UK (20/0006144)
  • King's College London (WT203148/Z/16/Z)
  • Engineering and Physical Sciences Research Council ([WT203148/Z/16/Z], WT 203148/Z/16/, 203148/ Z/16/Z)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
diabetic retinopathy, diabetic maculopathy, disease progression prediction, deep learning, multimodal prediction, diabetic retinopathy screening, external validation, retinal thickness, retinal thickness changes, retinal blood flow, retinal vessel density, retinal vessel diameter, retinal vessel tortuosity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review